Showing 651-660 of 9708 results for "".
Psoriasis Pipeline Update: JNJ-2113, A Novel Oral IL-23 Receptor Antagonist Peptide, Shows Promise in a Phase 2b Study
https://practicaldermatology.com/topics/psoriasis/psoriasis-pipeline-update-jnj-2113-a-novel-oral-il-23-receptor-antagonist-peptide-shows-promise-in-a-phase-2b-study/20207/Laura Korb Ferris, MD, PhD, discusses the topline results from a Phase 2b trial of JNJ-2113, a novel oral IL-23 receptor antagonist peptide that’s being developed for moderate-to-severe plaque psoriasis.Dispatches from the 2022 Skin of Color Update
https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.Success Factors in Selling A Dermatology Practice
https://practicaldermatology.com/topics/practice-management/success-factors-in-selling-a-dermatology-practice/23499/What to do if you’re considering a sale or merger.“No-touch” Surgical Excision & “Double-freeze-thaw” Cryotherapy Techniques
https://practicaldermatology.com/topics/skin-cancer-photoprotection/conjunctival-scc/19861/A 68-year-old white male with a history of basal cell carcinoma of the right lower eyelid, surgically excised 10 years prior to presentation, was referred to the Ocular Oncology Service at Wills Eye Hospital, Philadelphia for an asymptomatic conjunctival lesion on the right eye. The patient was treaMaking Connections: Success in Your First Five Years
https://practicaldermatology.com/topics/practice-management/webinar-making-connections-success-in-your-first-five-years/19819/Experts share practical guidance to help dermatologists chart a course for success. Topics range from getting involved in clinical trials to finding opportunities for leadership. Learn how to gain confidence prescribing systemic agents, and explore opportunities in medical dermatology.5 Missed Revenue Opportunities in Selling Skincare in Your Practice
https://practicaldermatology.com/topics/practice-management/5-missed-revenue-opportunities-in-selling-skincare-in-your-practice/20334/Most practices leave revenue on the table by making common skincare sales mistakes.On New Therapeutics and Real Sushi
https://practicaldermatology.com/series/the-practical-dermatology-podcast/on-new-therapeutics-and-real-sushi/32849/The latest news and updates, plus E. James Song, MD, FAAD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss the 2025 outlook for new therapeutics and play "Two Truths and a Lie." Dr. Song says he has been a wrestler, a jazz musician, and a sushi cheSkin of Color Session: Dr. Harris
https://practicaldermatology.com/programs/practical-dermatology/skin-of-color-session-dr-harris/32683/John E. Harris, MD, PhD, summarizes his vitiligo talk from the "Skin of Color Session" at Maui Derm 2025, during which he covered new therapeutic options for vitiligo as well as promising drugs in the pipeline and why they could be so impactful.FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
https://practicaldermatology.com/series/dermwire-tv/fda-approves-axillary-hyperhidrosis-treatment-study-examines-biologic-outcomes-psoriasis/26562/In this week's DermwireTV, the FDA approves a first-of-its-kind gel for axillary hyperhidrosis; a new analysis examines how smoking, BMI, and age affect biologic outcomes in psoriasis; and the CEO of Aerolase joins us to discuss the latest trends in the aesthetic laser market.Hidradenitis Suppurativa Treatment and the Use of Ultrasound
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-treatment-and-the-use-of-ultrasound/24013/Experts highlight recent research and treatment advancements in hidradenitis suppurativa.